GI Biome has officially changed its name to 'GI Longevity' and is embarking on a full-scale entry into the global anti-aging bio market.

Through 'GIB-7,' developed with its proprietary microbiome technology, the company has demonstrated its potential as an anti-aging therapeutic, showing efficacy in muscle strengthening and improving quality of life. Along with this name change, the company is also developing additional pipelines using various modalities to enhance immune function, cognitive function, and muscle strength, which are the core pillars of anti-aging.

CEO Bo Gie Yang  expressed his ambition to accelerate technology commercialization and business development, aiming to lead the global anti-aging industry.

Read more: https://www.dailypharm.com/user/news/3238